MedPath
FDA Approval

Terbutaline Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Lannett Company, Inc.
DUNS: 002277481
Effective Date
November 12, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Terbutaline(5 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Lannett Company, Inc.

Lannett Company, Inc.

006422406

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Terbutaline Sulfate

Product Details

NDC Product Code
0527-1311
Application Number
ANDA077152
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 27, 2022
Code: 576PU70Y8EClass: ACTIBQuantity: 5 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT

Terbutaline Sulfate

Product Details

NDC Product Code
0527-1318
Application Number
ANDA077152
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 27, 2022
Code: 576PU70Y8EClass: ACTIBQuantity: 2.5 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
© Copyright 2025. All Rights Reserved by MedPath